Any statements in this press release about our expectations, beliefs,
plans, objectives, assumptions or future events or performance are not
historical facts and are forward-looking statements. These statements are
often, but not always, made through the use of words or phrases such as
believe, will, expect, anticipate, estimate, intend, plan and would. For
example, statements concerning plans and objectives of management are
forward-looking statements. Forward-looking statements are not guarantees
of performance. They involve known and unknown risks, uncertainties and
assumptions that may cause actual results, levels of activity, performance
or achievements to differ materially from those expressed or implied. Some
of these risks, uncertainties and assumptions include, but are not limited
to, the risk that we cannot retain key executives. The foregoing sets forth
some, but not all, of the factors that could affect our ability to achieve
results described in any forward-looking statements. For additional
information about risks and uncertainties we face and a discussion of our
financial statements and footnotes, see documents we file with the SEC,
including our most recent annual report on Form 10-K and all subsequent
periodic reports. We assume no obligation and expressly disclaim any duty
to update forward-looking statements to reflect events or circumstances
after the date of this news release or to reflect the occurrence of
subsequent events.
Contact:
Michael Watts
Senior director, investor relations and corporate communications
858-410-8673
'/>"/>SOURCE Gen-Probe Incorporated Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 Related medicine news :1.
Richard Greco Joins Mediware Board2.
Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program3.
Sean P. McLaughlin Joins Red Cross as Chief of Operations Support4.
Dr. Mahesh Ramachandran Joins Marianjoy Medical Group5.
Nick Childs Joins Grey New York as Director of Content Development6.
Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book7.
David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager8.
NASN Joins Partnership to Fight Chronic Disease9.
AstraZeneca Joins Local Walking Movement10.
Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex11.
Fund Manager Joins Board of GSI Securitization Inc.